CH Biotech R&D Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 564.114 million compared to TWD 749.141 million a year ago. Operating income was TWD 248.188 million compared to TWD 394.861 million a year ago. Net income was TWD 178.671 million compared to TWD 312.114 million a year ago. Basic earnings per share was TWD 2.12 compared to TWD 3.7 a year ago. Diluted earnings per share was TWD 2.1 compared to TWD 3.65 a year ago.